Acorda CEO Cohen on U.S. Budget Cuts, Research

March 22 (Bloomberg) -- Ron Cohen, chief executive officer of Acorda Therapeutics Inc., talks about the impact of U.S. budget cuts on medical research and drug development. Cohen, speaking with Sara Eisen and Tom Keene on Bloomberg Television's "Surveillance," also discusses China's investment in medical care and science. (Source: Bloomberg)